Xvivo Perfusion AB 

$29.39
6
+$0.00+0% Friday 13:30

Statistics

Day High
29.39
Day Low
29.39
52W High
33.45
52W Low
16.98
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
76.6
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.04
0.02
0.07
0.12
Expected EPS
0.086901
Actual EPS
N/A

Financials

2.05%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
236.82MRevenue
4.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XVIPF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap104.85B
Medtronic offers products for cardiac and vascular surgeries, competing in the organ preservation segment.
Boston Scientific
BSX
Mkt Cap72.16B
Boston Scientific competes in the medical devices sector, including technologies for less invasive surgeries.
Stryker
SYK
Mkt Cap117.18B
Stryker provides medical devices for various surgeries, indirectly competing in the organ transplant space.
Intuitive Surgical
ISRG
Mkt Cap149.48B
Intuitive Surgical's robotic-assisted surgical systems can be used in transplant surgeries, offering an alternative to traditional methods.
Edwards Lifesciences
EW
Mkt Cap49.5B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular market.
Abbott Laboratories
ABT
Mkt Cap158.63B
Abbott Laboratories offers medical devices, diagnostics, and nutrition products that serve similar patient groups as XVIVO.
Baxter International
BAX
Mkt Cap10.01B
Baxter International provides a range of hospital and renal products, including organ preservation solutions.
Zimmer Biomet
ZBH
Mkt Cap16.9B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, including products that can be used in transplant surgeries.
Johnson & Johnson
JNJ
Mkt Cap560.33B
Johnson & Johnson's medical devices segment offers products that can be used in various surgeries, including organ transplants.
Danaher
DHR
Mkt Cap130.44B
Danaher Corporation's life sciences and diagnostics segments offer products that can be used in the organ transplant process.

About

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Show more...
CEO
Mr. Christoffer Rosenblad
Employees
193
Country
Sweden
ISIN
SE0004840718

Listings

0 Comments

Share your thoughts

FAQ

What is Xvivo Perfusion AB stock price today?
The current price of XVIPF is $29.39 USD — it has increased by +0% in the past 24 hours. Watch Xvivo Perfusion AB stock price performance more closely on the chart.
What is Xvivo Perfusion AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Xvivo Perfusion AB stocks are traded under the ticker XVIPF.
When is the next Xvivo Perfusion AB earnings date?
Xvivo Perfusion AB is going to release the next earnings report on July 14, 2026.
What were Xvivo Perfusion AB earnings last quarter?
XVIPF earnings for the last quarter are 0.12 USD per share, whereas the estimation was 0.1 USD resulting in a +24.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xvivo Perfusion AB revenue for the last year?
Xvivo Perfusion AB revenue for the last year amounts to 236.82M USD.
What is Xvivo Perfusion AB net income for the last year?
XVIPF net income for the last year is 4.85M USD.
How many employees does Xvivo Perfusion AB have?
As of June 12, 2026, the company has 193 employees.
In which sector is Xvivo Perfusion AB located?
Xvivo Perfusion AB operates in the Health & Wellness sector.
When did Xvivo Perfusion AB complete a stock split?
Xvivo Perfusion AB has not had any recent stock splits.
Where is Xvivo Perfusion AB headquartered?
Xvivo Perfusion AB is headquartered in Mölndal, Sweden.